Clinical Trial Update: A Study to Evaluate Safety and Efficacy of PBK_M2502 [Phase 3]

View source ↗

Summary

Phase 3 clinical study evaluating safety and efficacy of PBK_M2502; the trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Diseases
• Digestive System Diseases
• Gastrointestinal Diseases
• Intestinal Diseases

Drugs mentioned

• PBK_M2502

Snippet

Sponsor: Pharmbio Korea Co., Ltd. | Conditions: Intestinal Disease, Colonic Diseases | Phase 3 | Status: NOT_YET_RECRUITING